Skip to content
Dr. Grey AI

Peptide

KPV

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) that exhibits potent anti-inflammatory and immunomodulatory properties. Preclinical studies have demonstrated significant efficacy in reducing intestinal inflammation in multiple models of inflammatory bowel disease, including DSS- and TNBS-induced colitis. Unlike full-length α-MSH, KPV's anti-inflammatory action is not primarily melanocortin receptor-mediated but is instead transported into cells via the PepT1 transporter. No human clinical trials have been conducted to date, limiting the evidence to animal and in vitro studies.

Research notice. This page is for education and research. Peptides may not be FDA-approved for human use and may only be legally available for research. Talk to a qualified clinician before considering any peptide.

Best evidence
Grade C
Conditions studied
3
Outcomes
12
Graded outcomes
0084

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

3 conditions, plus general outcomes

Immune Health: outcomes studied for KPV
GradeOutcomeEffectSizeStudiesPeopleStudies list
Pro-inflammatory Cytokine Reduction

Inhibition of TNF-α, IL-1β, and IL-6 secretion at nanomolar concentrations

Changes; see studiesModerate effect70 studies90 people

Studies that measured pro-inflammatory cytokine reduction

and 60 more in the citations list

Macrophage Activation Suppression

Inhibition of LPS-induced cytokine synthesis and CD86 expression

Changes; see studiesModerate effect69 studies60 people

Studies that measured macrophage activation suppression

and 59 more in the citations list

General Gut Health: outcomes studied for KPV
GradeOutcomeEffectSizeStudiesPeopleStudies list
Colitis Severity (Animal)

Significant reduction in inflammatory infiltrates and MPO activity in DSS and TNBS colitis models

Improves (the measure goes down)Large effect69 studies120 people

Studies that measured colitis severity (animal)

and 59 more in the citations list

Intestinal Inflammation (Animal)

Rescued all animals from death in MC1R-deficient mice during DSS colitis

Improves (the measure goes down)Large effect68 studies150 people

Studies that measured intestinal inflammation (animal)

and 58 more in the citations list

General

  • GI Protection: improves
  • Immune Function: improves
  • Anti-Cancer Activity: improves
General: outcomes studied for KPV
GradeOutcomeEffectSizeStudiesPeopleStudies list
GI Protection

10 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes up)Moderate effect13 studies

Studies that measured gi protection

and 3 more in the citations list

Immune Function

9 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes up)Moderate effect12 studies

Studies that measured immune function

and 2 more in the citations list

Anti-Cancer Activity

6 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes up)Small effect9 studies

Studies that measured anti-cancer activity

Wound Healing

4 systematic reviews and preclinical studies support this finding. Evidence includes systematic reviews/meta-analyses. Primarily preclinical evidence.

Improves (the measure goes up)Small effect7 studies
Pulmonary Function

3 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes up)Small effect6 studies
Antimicrobial Activity

2 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes up)Small effect5 studies
Mortality

2 preclinical studies support this finding. Primarily preclinical evidence.

Improves (the measure goes down)Small effect5 studies

Skin Health

  • Anti-inflammatory (Topical): improves
Skin Health: outcomes studied for KPV
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anti-inflammatory (Topical)

Anti-inflammatory effect in crystal-induced peritonitis model

Improves (the measure goes down)Moderate effect68 studies30 people

Studies that measured anti-inflammatory (topical)

and 58 more in the citations list

Key findings

  • Pro-inflammatory Cytokine ReductionImmune HealthChanges; see studies
  • Colitis Severity (Animal)General Gut HealthImproves (the measure goes down)
  • Intestinal Inflammation (Animal)General Gut HealthImproves (the measure goes down)

Studies cited

48 studies from PubMed

  1. Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.Science advances, 2026 · PMID 41533788
  2. Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.International journal of medical sciences, 2025 · PMID 41209547
  3. Challenges in clinical nutrition research in Latin America: A narrative review.Clinical nutrition ESPEN, 2025 · PMID 41176232
  4. A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.Bioactive materials, 2024 · PMID 37859689
  5. PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS.Frontiers in pharmacology, 2024 · PMID 39211778
  6. Non-contrast-enhanced magnetic resonance urography for measuring split kidney function in pediatric patients with hydronephrosis: comparison with renal scintigraphy.Pediatric nephrology (Berlin, Germany), 2024 · PMID 38041747
  7. Learnings from the first AI-enabled skin cancer device for primary care authorized by FDA.NPJ digital medicine, 2024 · PMID 38879640
  8. Growth Factors-Loaded Temperature-Sensitive Hydrogel as Biomimetic Mucus Attenuated Murine Ulcerative Colitis via Repairing the Mucosal Barriers.ACS applied materials & interfaces, 2024 · PMID 38289234
  9. The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.Cells, 2023 · PMID 37508552
  10. Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer.Oncogene, 2023 · PMID 37161053
  11. Digital health technology in clinical trials.NPJ digital medicine, 2023 · PMID 37202443
  12. Interobserver Variability in CT-based Morphologic Tumor Response Assessment of Colorectal Liver Metastases.Radiology. Imaging cancer, 2022 · PMID 35522139
  13. Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healing.International journal of biological macromolecules, 2022 · PMID 36240893
  14. A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.Acta biomaterialia, 2022 · PMID 35245681
  15. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.The New England journal of medicine, 2022 · PMID 35320643
  16. Nocturnal Hypoventilation as a Respiratory Complication of Acute Flaccid Myelitis.The Journal of pediatrics, 2022 · PMID 35605645
  17. In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis.Biomaterials science, 2021 · PMID 34846053
  18. Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H(2)O(2)-Induced Vitiligo Mouse Model.ACS nano, 2021 · PMID 34662120
  19. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.ACS biomaterials science & engineering, 2021 · PMID 34547895
  20. Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to Immunomodulation.Pediatrics, 2020 · PMID 32015180
  21. A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis.Biomaterials science, 2019 · PMID 31408067
  22. Are melanocortin peptides future therapeutics for cutaneous wound healing?Experimental dermatology, 2019 · PMID 30661264
  23. Mortality Risk Associated With Truncating Founder Mutations in Titin.Circulation. Genomic and precision medicine, 2019 · PMID 31112426
  24. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Molecular therapy : the journal of the American Society of Gene Therapy, 2017 · PMID 28143741
  25. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.Journal of pharmaceutical sciences, 2017 · PMID 28343991
  26. Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative Colitis.ACS applied materials & interfaces, 2017 · PMID 28349696
  27. Structural and immunological feature of rhamnogalacturonan I-rich polysaccharide from Korean persimmon vinegar.International journal of biological macromolecules, 2016 · PMID 27131731
  28. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.Cellular and molecular gastroenterology and hepatology, 2016 · PMID 27458604
  29. Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.Circulation. Cardiovascular interventions, 2016 · PMID 27899408
  30. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.International journal of physiology, pathophysiology and pharmacology, 2012 · PMID 22837805
  31. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.Advances in experimental medicine and biology, 2010 · PMID 21222263
  32. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.Gastroenterology, 2010 · PMID 19909746
  33. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationGastroenterology, 2008 · PMID 18061177
  34. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseaseInflamm Bowel Dis, 2008 · PMID 18092346
  35. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.Endocrine reviews, 2008 · PMID 18612139
  36. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.Annals of the rheumatic diseases, 2007 · PMID 17934097
  37. The antiinflammatory peptide alpha-melanocyte-stimulating hormone protects against the development of experimental colitisRegul Pept, 2006 · PMID 16401417
  38. Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.Peptides, 2006 · PMID 16274845
  39. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide.Experimental eye research, 2006 · PMID 16965771
  40. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptidesJ Leukoc Biol, 2003 · PMID 12750433
  41. New insights into the functions of alpha-MSH and related peptides in the immune system.Annals of the New York Academy of Sciences, 2003 · PMID 12851308
  42. The tripeptide Lys-Pro-Val inhibits LPS-induced synthesis of cytokines and expression of CD86 on macrophagesJ Immunol, 2002 · PMID 11937135
  43. Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats.Critical care medicine, 2002 · PMID 11990926
  44. Downregulation of glucocorticoid receptors of liver cytosols and the role of the inflammatory cytokines in pathological stress in scalded rats.Burns : journal of the International Society for Burn Injuries, 2002 · PMID 12052369
  45. [Changes in aldosterone binding activity of kidney cytosol after stress in rats and the regulation].Sheng li xue bao : [Acta physiologica Sinica], 2001 · PMID 11833422
  46. The neuroimmunomodulatory peptide alpha-MSH.Annals of the New York Academy of Sciences, 2000 · PMID 11268347
  47. Antimicrobial effects of alpha-MSH peptides.Journal of leukocyte biology, 2000 · PMID 10670585
  48. Immunization against poliomyelitis: risk/benefit/cost in a changing context.Developments in biological standardization, 1979 · PMID 230106